PHYSIOLOGICAL AND CLINICAL EFFECTS OF AMYLOBARBITONE SODIUM THERAPY IN PATIENTS WITH ANXIETY STATES.
D000654:Amobarbital; D001007:Anxiety; D001008:Anxiety Disorders; D035843:Biomedical Research; D004358:Drug Therapy; D005712:Galvanic Skin Response; D006801:Humans; D010600:Pharmacology; D010919:Placebos; D011603:Psychophysiology; D012964:Sodium
D010919:Placebos; D012964:Sodium; D000654:Amobarbital
AMOBARBITAL; ANXIETY; CLINICAL RESEARCH; DRUG THERAPY; GALVANIC SKIN RESPONSE; PHARMACOLOGY; PLACEBOS; PSYCHOPHYSIOLOGY